Literature DB >> 9918598

Anxiolytic 5-hydroxytryptamine1A agonists suppress firing activity of dorsal hippocampus CA1 pyramidal neurons through a postsynaptic mechanism: single-unit study in unanesthetized, unrestrained rats.

K Tada1, K Kasamo, N Ueda, T Suzuki, T Kojima, K Ishikawa.   

Abstract

Recent behavioral studies indicate that conditioned fear response to contextual stimuli is reduced effectively by anxiolytic 5-hydroxytryptame (5-HT)1A agonists. Since the hippocampus seems to play an essential role in associative fear memories evoked by context, it is important to assess the effect of 5-HT1A agonists on pyramidal cell activity in the hippocampus. We examined the effects of 5-HT1A agonists on the spontaneous firing rate of hippocampal CA1 pyramidal neurons in unanesthetized, unrestrained rats. Systemic administration of selective 5-HT1A agonists, 8-hydroxy-2-(di-n-propylamino)tetralin, buspirone, ipsapirone, and flesinoxan produced a dose-dependent inhibition of neuronal activity. Putative 5-HT1A antagonists NAN-190 1-(2-methoxyphenyl)-4-[4-(2-phthalimido)butyl]piperazine and (-)-pindolol did not change neuronal activity of CA1 pyramidal neurons. The suppression of neuronal activity by buspirone was antagonized by NAN-190 but not by (-)-pindolol. Lack of antagonistic activity of (-)-pindolol for the suppression of pyramidal neurons via a postsynaptic mechanism is consistent with the results of recent electrophysiological experiments in anesthetized rats. Pretreatment with parachlorphenylalanine did not change the spontaneous firing rates of hippocampal CA1 pyramidal neurons or abolish the suppressant effects of buspirone on these neurons. Taken together, the present results strongly suggest that suppression of the hippocampal CA1 pyramidal neuronal activity by anxiolytic 5-HT1A agonists in awake rats is mediated by postsynaptic 5-HT1A receptors located on pyramidal neurons.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9918598

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  11 in total

1.  Effects of sustained (+/-)pindolol administration on serotonin neurotransmission in rats.

Authors:  N Haddjeri; P Blier
Journal:  J Psychiatry Neurosci       Date:  2000-09       Impact factor: 6.186

Review 2.  Therapeutic role of 5-HT1A receptors in the treatment of schizophrenia and Parkinson's disease.

Authors:  Yukihiro Ohno
Journal:  CNS Neurosci Ther       Date:  2010-11-21       Impact factor: 5.243

Review 3.  5-HT1A receptor-regulated signal transduction pathways in brain.

Authors:  Abigail M Polter; Xiaohua Li
Journal:  Cell Signal       Date:  2010-04-02       Impact factor: 4.315

4.  Preclinical and clinical characterization of the selective 5-HT(1A) receptor antagonist DU-125530 for antidepressant treatment.

Authors:  M C Scorza; L Lladó-Pelfort; S Oller; R Cortés; D Puigdemont; M J Portella; R Pérez-Egea; E Alvarez; P Celada; V Pérez; F Artigas
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

5.  Involvement of the 5-HT1A receptors in classical fear conditioning in C57BL/6J mice.

Authors:  O Stiedl; I Misane; J Spiess; S O Ogren
Journal:  J Neurosci       Date:  2000-11-15       Impact factor: 6.167

6.  The Effect of Orexin-2 and Endocannabinoid-1 Antagonists on Neuronal Activity of Hippocampal CA1 Pyramidal Neurons in Response to Tramadol in Rats.

Authors:  Vajihe Imanpour; Parham Reisi
Journal:  Adv Biomed Res       Date:  2022-03-30

7.  Improving the Treatment of Parkinson's Disease: A Novel Approach by Modulating 5-HT(1A) Receptors.

Authors:  Saki Shimizu; Yukihiro Ohno
Journal:  Aging Dis       Date:  2012-11-29       Impact factor: 6.745

8.  In vivo electrophysiological assessment of the putative antidepressant Wf-516 in the rat raphe dorsalis, locus coeruleus and hippocampus.

Authors:  M El Mansari; P Blier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-11-30       Impact factor: 3.000

Review 9.  The therapeutic role of 5-HT1A and 5-HT2A receptors in depression.

Authors:  Pau Celada; M Puig; Mercè Amargós-Bosch; Albert Adell; Francesc Artigas
Journal:  J Psychiatry Neurosci       Date:  2004-07       Impact factor: 6.186

10.  Serotonin modulation of cortical neurons and networks.

Authors:  Pau Celada; M Victoria Puig; Francesc Artigas
Journal:  Front Integr Neurosci       Date:  2013-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.